Robert W. Wilkinson

13.7k total citations · 2 hit papers
307 papers, 8.7k citations indexed

About

Robert W. Wilkinson is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Robert W. Wilkinson has authored 307 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 67 papers in Pulmonary and Respiratory Medicine and 66 papers in Oncology. Recurrent topics in Robert W. Wilkinson's work include Electrolyte and hormonal disorders (35 papers), Cancer Immunotherapy and Biomarkers (29 papers) and Bipolar Disorder and Treatment (28 papers). Robert W. Wilkinson is often cited by papers focused on Electrolyte and hormonal disorders (35 papers), Cancer Immunotherapy and Biomarkers (29 papers) and Bipolar Disorder and Treatment (28 papers). Robert W. Wilkinson collaborates with scholars based in United Kingdom, United States and Japan. Robert W. Wilkinson's co-authors include Simon J. Dovedi, Jamie Honeychurch, Ross Stewart, Tim Illidge, Edmund Poon, Michelle Morrow, Ian J. Stratford, Amy L. Adlard, Eleanor J. Cheadle and David R. Appleton and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Robert W. Wilkinson

299 papers receiving 8.3k citations

Hit Papers

Acquired Resistance t... 1980 2026 1995 2010 2014 1980 250 500 750

Peers

Robert W. Wilkinson
Luan D. Truong United States
A.R. Bradwell United Kingdom
Matthew D. Griffin United States
Nicholas Topley United Kingdom
Robert W. Wilkinson
Citations per year, relative to Robert W. Wilkinson Robert W. Wilkinson (= 1×) peers Gerhard A. Müller

Countries citing papers authored by Robert W. Wilkinson

Since Specialization
Citations

This map shows the geographic impact of Robert W. Wilkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Wilkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Wilkinson more than expected).

Fields of papers citing papers by Robert W. Wilkinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert W. Wilkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Wilkinson. The network helps show where Robert W. Wilkinson may publish in the future.

Co-authorship network of co-authors of Robert W. Wilkinson

This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Wilkinson. A scholar is included among the top collaborators of Robert W. Wilkinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Wilkinson. Robert W. Wilkinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watson, Matthew D., Steven Hayward, Robert W. Wilkinson, et al.. (2025). Folded pseudochiral Fermi surface in 4Hb-TaSe2 from band hybridization with a charge density wave. Communications Materials. 6(1).
2.
Walker, Jennifer A., Michelle Morrow, Viia Valge-Archer, et al.. (2023). Age-induced changes in anti-tumor immunity alter the tumor immune infiltrate and impact response to immuno-oncology treatments. Frontiers in Immunology. 14. 1258291–1258291. 9 indexed citations
3.
Dovedi, Simon J., Viia Valge-Archer, Amit Grover, et al.. (2023). Small Gene Networks Delineate Immune Cell States and Characterize Immunotherapy Response in Melanoma. Cancer Immunology Research. 11(8). 1125–1136. 2 indexed citations
4.
Gitto, Sarah B., Gareth Davies, Sushil Kumar, et al.. (2023). A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression. Clinical Cancer Research. 30(8). 1567–1581. 16 indexed citations
5.
Harper, James A., Shannon Burke, Jon Travers, et al.. (2021). Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity. Molecular Cancer Therapeutics. 20(9). 1723–1734. 10 indexed citations
6.
Dovedi, Simon J., Eleanor J. Cheadle, Edmund Poon, et al.. (2017). Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 Blockade. Clinical Cancer Research. 23(18). 5514–5526. 263 indexed citations
7.
Xie, Bangwen, Michal R. Tomaszewski, André Neves, et al.. (2017). Optoacoustic Detection of Early Therapy-Induced Tumor Cell Death Using a Targeted Imaging Agent. Clinical Cancer Research. 23(22). 6893–6903. 24 indexed citations
8.
Dovedi, Simon J., Amy L. Adlard, Grazyna Lipowska‐Bhalla, et al.. (2014). Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade. Cancer Research. 74(19). 5458–5468. 974 indexed citations breakdown →
9.
Holt, Sarah V., Armelle Logié, Barry R. Davies, et al.. (2012). Enhanced Apoptosis and Tumor Growth Suppression Elicited by Combination of MEK (Selumetinib) and mTOR Kinase Inhibitors (AZD8055). Cancer Research. 72(7). 1804–1813. 70 indexed citations
10.
Thompson, David F., Filippos Michopoulos, Christopher J. Smith, et al.. (2011). Profiling biological samples using ultra performance liquid chromatography–inductively coupled plasma–mass spectrometry (UPLC-ICP-MS) for the determination of phosphorus and sulfur-containing metabolites. Molecular BioSystems. 7(4). 1149–1157. 8 indexed citations
11.
Shannon, Aoife M., Brian A. Telfer, Paul D. Smith, et al.. (2009). The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) Enhances the Radiation Responsiveness of Lung and Colorectal Tumor Xenografts. Clinical Cancer Research. 15(21). 6619–6629. 42 indexed citations
12.
Pearce, Daniel J., Robert W. Wilkinson, Claire Crafter, et al.. (2009). AZD1152 Rapidly and Negatively Affects the Growth and Survival of Human Acute Myeloid Leukemia Cells In vitro and In vivo. Cancer Research. 69(10). 4150–4158. 62 indexed citations
13.
Byth, Kate F., Andrew P. Thomas, Gareth Hughes, et al.. (2009). AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts. Molecular Cancer Therapeutics. 8(7). 1856–1866. 104 indexed citations
14.
Michopoulos, Filippos, Helen Gika, Georgios Theodoridis, et al.. (2009). Methodological considerations in the development of HPLC-MS methods for the analysis of rodent plasma for metabonomic studies. Molecular BioSystems. 6(1). 108–120. 39 indexed citations
15.
Camplejohn, Richard S., Ian R. Hart, Robert W. Wilkinson, et al.. (2004). Oral Presentations 5. British Journal of Cancer. 91(S1). S16–S17. 1 indexed citations
16.
Molina, Antonio Morey, et al.. (1992). The influence of changing age and referral for end-stage renal failure in Newcastle upon Tyne.. PubMed. 24(4). 142–5. 1 indexed citations
17.
Goodship, Timothy H.J., A. Heaton, R. S. C. Rodger, et al.. (1984). Factors affecting development of peritonitis in continuous ambulatory peritoneal dialysis.. BMJ. 289(6457). 1485–1486. 6 indexed citations
18.
Wilkinson, Robert W., et al.. (1976). The effect of recurrent early homograft rejection on subsequent patient and renal graft survival.. PubMed. 6(3). 375–8. 1 indexed citations
19.
Wilkinson, Robert W.. (1975). Tunen tone changes and derived phonological contrast. Language. 51(3). 561–575. 1 indexed citations
20.
Wilkinson, Robert W.. (1974). A phonetic constraint on a syncope rule in Telugu. Language. 50(3). 478–497. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026